VAERS reports by lot

Novartis Vaccines Meningococcal lot ABXB28AA: VAERS reports

20 VAERS reports list lot ABXB28AA as a Novartis Vaccines Meningococcal vaccine, received between 2021-04-30 and 2022-10-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
5%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1232%
Neurological924%
General / Systemic (non-local)616%
Gastrointestinal411%
Musculoskeletal38%
Cardiac / Cardiovascular25%
Allergic / Anaphylactic13%
Dermatological (non-injection-site)13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Louisiana3
California3
Texas2
Michigan2
Maryland2
Connecticut1
Florida1
Ohio1
Virginia1
Arizona1
Arkansas1
Rhode Island1

Reports by month received

2021-041
2021-052
2021-062
2021-073
2021-083
2021-092
2021-121
2022-073
2022-082
2022-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.